LADENBURG THALMANN FINANCIAL SERVICES INC. - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 173 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2019. The put-call ratio across all filers is 2.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q4 2019$13,000
+85.7%
279
+68.1%
0.00%
Q3 2019$7,000
-36.4%
1660.0%0.00%
Q2 2019$11,000
+57.1%
166
+67.7%
0.00%
Q1 2019$7,000
+40.0%
990.0%0.00%
Q4 2018$5,000
+400.0%
99
+330.4%
0.00%
Q2 2018$1,0000.0%230.0%0.00%
Q1 2018$1,000
-99.3%
23
-99.3%
0.00%
-100.0%
Q4 2017$152,000
+1069.2%
3,273
+1246.9%
0.00%
Q3 2017$13,000
+333.3%
243
+465.1%
0.00%
Q2 2017$3,000
-70.0%
43
-69.9%
0.00%
Q1 2017$10,000
-16.7%
143
-10.1%
0.00%
Q4 2016$12,000
+140.0%
159
+169.5%
0.00%
Q3 2016$5,00059
+883.3%
0.00%
Q2 2016$060.0%0.00%
Q1 2016$0
-100.0%
6
-50.0%
0.00%
Q4 2015$1,0000.0%120.0%0.00%
Q3 2015$1,00012
+50.0%
0.00%
Q3 2014$080.00%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q3 2019
NameSharesValueWeighting ↓
First Light Asset Management, LLC 213,887$29,608,0002.19%
Rock Springs Capital Management LP 566,500$78,421,0001.66%
FEDERATED HERMES, INC. 4,280,528$592,554,0001.21%
AtonRa Partners 17,646$2,443,0001.20%
EMERALD MUTUAL FUND ADVISERS TRUST 218,390$30,232,0001.05%
EMERALD ADVISERS, LLC 226,875$31,406,0001.04%
Atika Capital Management LLC 89,000$12,319,0000.96%
Capital Impact Advisors, LLC 25,582$3,541,0000.87%
JGP Global Gestao de Recursos Ltda. 1,586$220,0000.83%
CAPITAL INTERNATIONAL LTD /CA/ 79,742$11,039,0000.64%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders